傑瑞股份(002353.SZ):截至2023年末海外業務收入佔比已經達到46.85%
格隆匯5月15日丨傑瑞股份(002353.SZ)近日在接待機構投資者調研時表示,公司將繼續堅定不移的實施全球化發展道路,形成強韌穩固的海外國內雙市場發展格局,不斷提升公司的市場佔有率。目前,海外戰略佈局取得顯著成效,業務遍佈70多個國家和地區,截至2023年末,公司海外業務收入佔比已經達到46.85%。未來,公司要繼續加強海外重點市場的資源投入,夯實區域中心職能,建設本地化和屬地化管理能力;繼續深耕油氣領域,快速提升主要業務板塊的海外市場佔有率,確立市場的領先地位;加大力量聚焦國際市場新業務、新領域開發,加緊探索鋰電池資源化回收利用等領域的發展機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.